AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Board/Management Information 2020
Aug 19, 2020
61842_rns_2020-08-19_cf4ff28f-f360-438d-810c-3fa1734f0304.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited Batra Centre
No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
August 18, 2020
The BSE Limited
Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001 Scrip Code: 541540
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Sandra (E), Mumbai - 400 051 Scrip Code: SOLARA
Dear Sir/ Madam,
Sub: Change in Management / Appointment of Chief Financial Officer
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Subhash Anand joins the company as the new CFO and will succeed incumbent Executive Director and CFO Mr. Hariharan Subramaniam who retires in March 2021
Mr. Subhash Anand will transition over the coming months with Mr. Hariharan Subramaniam and eventually succeed as Executive Director and CFO by the end of FY 2020 – ‘21.
Press release on appointment of Mr. Subhash Anand (with brief profile) is enclosed.
We request you to take the same on record.
Thanking you, Yours Truly,
For Solara Active Pharma Sciences Limited
==> picture [146 x 39] intentionally omitted <==
S. Murali Krishna Company Secretary
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
PRESS RELEASE
==> picture [165 x 55] intentionally omitted <==
WWW.SOLARA.CO.IN | BSE:541540 NSE: SOLARA BLOOMBERG: SOLARA: IN | SECTOR: PHARMACEUTICALS
Solara announces onboarding of new CFO
Subhash Anand joins Solara as the new CFO and will succeed incumbent Hariharan Subramaniam who retires in March 2021
Bangalore, August 19, 2020: Solara Active Pharma Sciences Limited (Solara), one of India’s leading pureplay active pharmaceutical ingredients Company today announces the appointment of Subhash Anand (Subhash) as the new Chief Financial Officer (CFO) to succeed Hariharan Subramaniam(Hari) the incumbent CFO and Executive Director of the Company.
Subhash joins the Company from PI Industries Limited(PIIL) where he was the President and CFO. He brings a wealth of experience across the full array of the finance function. Before PIIL, he worked in Whirlpool, Sterlite Industries, Hindustan Copper Ltd and Calcom in senior finance roles. Subhash is a qualified AICWA (India) & Certified Management Accountant (CMA) from the Institute of Management Accountants (USA). With his rich experience and excellent track record, Subhash will strengthen the leadership team of Solara, as it enters the next phase of accelerating growth and delivering superior returns to all its stakeholders.
Subhash will transition over the coming months with Hari and eventually succeed Hari as Executive Director and CFO by the end of FY21. The Board appointed Hari in April 2017, and since then, Hari has been an integral part of the journey of Solara from being a new entrant in the API space to becoming a leading standalone API Company with scale, and scope.
About Solara Active Pharma Sciences
Solara Active Pharma Sciences Ltd (BSE-541540, NSE-SOLARA) headquartered in Bengaluru, India offers a basket of diversified, high-value Commercial APIs and Contract manufacturing services in over 75 countries. It has a manufacturing base comprising five globally compliant API facilities, with approvals including the USFDA, EU GMP and PMDA in Japan.
Investor / Analyst contact Statutory and corporate affairs Abhishek Singhal Murali Krishna S Investor Relations Consultant Raghavan. V [email protected] [email protected]
+91 44 4344 6700